MA
Therapeutic Areas
Exact Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CancerGuard™ | Multi-Cancer Early Detection | Pivotal Studies |
| Oncotype DX® AR-V7 Nucleus Detect™ | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Commercial |
| ctDNA MRD Monitoring | Colorectal Cancer (Stage II/III) | Clinical Validation |
| Next-Generation Cologuard® | Colorectal Cancer Screening | Development |
Leadership Team at Exact Sciences
KT
Kevin T. Conroy
Chairman & Chief Executive Officer
JT
Jeffrey T. Elliott
Chief Financial Officer
EC
Everett Cunningham
Chief Commercial Officer
FD
Francis deSouza
Lead Independent Director
DJ
Dr. Jorge Garces
Chief Science Officer
DP
Dr. Paul J. Limburg
Chief Medical Officer, Screening